DNA (DNA) Token Market Analyzer
Current Market Snapshot
This tool displays real-time data from major trackers for DNA (DNA) token.
CoinStats Data
CoinCodex Data
Risk Assessment
Key risk factors for investing in DNA (DNA) token:
- Supply Ambiguity High
- Liquidity Crunch Medium
- Price Volatility High
- Community Vacuum High
- Regulatory Exposure Medium
- Prediction Uncertainty High
Technical Indicators
Prediction Overview
Forecast models show wide variation in expected outcomes:
- PricePrediction.net: $0.00001 by end of 2025 (500x gain)
- Same model: $0.0000017747717970900053 by 2025 and 2030
- DigitalCoinPrice: 0.00 average price level around 2032
- CoinCodex: 25.31% decline to $0.00000000001265
- 2026 forecasts range from 4.9 × 10⁻⁸ to 7.5 × 10⁻⁷
Investment Recommendation
Based on current data:
- Low transparency and lack of public documentation
- Minimal trading volume and liquidity concerns
- High volatility and uncertain future projections
- No active community or development team
Summary
This tool highlights the key aspects of DNA (DNA) token including its market data, technical signals, and investment risks. Due to the lack of transparency and limited data, this token is categorized as a high-risk speculative asset.
When you type "DNA" into a crypto tracker you’ll see a jumble of tiny numbers, conflicting charts, and a lot of unanswered questions. The token’s ticker symbol appears on several listing sites, but the data rarely matches. If you’re wondering what the DNA crypto coin actually is and whether it’s worth a glance, this guide walks through the token’s definition, market snapshot, technical signals, community presence, and the risks you’ll face as an investor.
What is DNA (DNA) crypto coin?
DNA (DNA) is a cryptocurrency token that currently trades at a few×10⁻¹⁸USD per unit. The token shows up on multiple market‑data platforms under the same ticker, which has led to a lot of confusion about its true supply, underlying blockchain, and even its existence.
Unlike well‑known coins that publish a whitepaper, roadmap, or development team, DNA offers virtually no public documentation. The lack of a clear project narrative means the token is often lumped into the micro‑cap cryptocurrency category, where dozens of tokens compete for a sliver of investor attention.
Where does DNA appear on market trackers?
Two of the most visited price aggregators - CoinStats and CoinCodex - list slightly different numbers for DNA. The discrepancies illustrate why investors should double‑check any data point before acting.
| Metric | CoinStats | CoinCodex |
|---|---|---|
| Current price | $0.0000000000178 | $0.0₁₀1738 (≈1.74×10⁻¹⁸USD) |
| Market cap | $745,709 | ~$730,000 |
| 24‑hour volume | $117,330 | $115,000 |
| Circulating supply | 0DNA | 0DNA |
| All‑time high (USD) | $0.0000000000235 (Dec62024) | $0.0000000000240 (Dec62024) |
| All‑time low (USD) | $0.0000000000095 (Jul172025) | $0.0000000000098 (Jul172025) |
The table shows the token hovering around a sub‑nano‑dollar price, a market cap under $1million, and a trading volume that barely scratches $120K daily. Those figures place DNA deep in the micro‑cap tier where liquidity is thin and price swings can be caused by a single large order.
Tokenomics that raise red flags
One of the first things any serious investor checks is supply data. DNA lists **both circulating supply and maximum supply as 0**, which is mathematically impossible for a tradable asset. This might be a data‑entry error, but it also hints that the token’s smart contract could be mis‑configured or that the project simply never published accurate token‑omics.
Without a reliable supply metric, calculating meaningful valuation ratios (price‑to‑market‑cap, volume‑to‑market‑cap) becomes speculative. The 15.73% volume‑to‑market‑cap ratio looks healthy on paper, yet the underlying numbers are so small that a few hundred dollars of buying pressure could inflate the ratio dramatically.
Price performance and technical signals
Since its debut, DNA’s price has been highly volatile. It hit its all‑time high in December2024, slipped to a low in July2025, and now trades in the low‑single‑e‑18 range. Technical indicators paint a mixed picture:
- 14‑day Relative Strength Index (RSI) sits at 43.38, suggesting slight bearish momentum but not an oversold condition.
- 50‑day Simple Moving Average (SMA) is roughly $0.0₁₀1828, while the 200‑day SMA is slightly lower at $0.0₁₀1898 - the price is marginally above both averages.
- The Fear & Greed Index reads **50 (Neutral)**, but broader market sentiment for DNA is classified as **Bearish** on most tracking sites.
These signals suggest the token is not in a strong uptrend. The moving averages are practically flat because the price changes are minuscule; any breakout would need a genuine influx of buying interest.
What the prediction platforms are saying
Because DNA is so low‑priced, many forecasting engines output numbers that look like scientific notation glitches. Here’s a quick snapshot of the most cited outlooks:
- PricePrediction.net projects a rise to $0.00001 by the end of 2025 - a 500‑times jump from current levels, but still under $0.01.
- Another model from the same site predicts a more modest $0.0000017747717970900053 by 2025 and the same target for 2030.
- DigitalCoinPrice foresees DNA crossing the “0.00 average price level” around 2032, though the exact figure is corrupted in the data dump.
- CoinCodex warns of a 25.31% decline, taking the price down to $0.0₁₀1265.
- For 2026, forecasts range wildly from 4.9×10⁻⁸ to 7.5×10⁻⁷, reflecting extreme uncertainty.
In plain English: the predictions swing from “tiny upside potential” to “likely further decline.” The spread tells you that no analyst feels confident about DNA’s direction, which is typical for micro‑caps with scant data.
Community and development activity - or the lack thereof
Search Reddit, Twitter/X, or dedicated crypto forums and you’ll find almost nothing about DNA. The token does not appear in trending lists, and there are no official social‑media handles tied to a development team. Without a community, there’s no crowd‑sourced research, no bug‑reports, and no roadmap updates.
Technical documentation is missing as well. No whitepaper, no GitHub repository, and no publicly verified smart‑contract address have been identified. This makes it practically impossible to verify whether the token runs on Ethereum, Binance Smart Chain, or a custom chain.
Investment risk assessment - should you even consider DNA?
Given the data above, here are the key risk factors to keep in mind:
- Supply ambiguity: Reported supply of 0 raises questions about contract integrity.
- Liquidity crunch: Daily volume under $120K means large orders can move the price dramatically.
- Price volatility: While the % swing looks modest, the absolute price is so low that a small change appears huge on a percentage basis.
- Community vacuum: No active users, developers, or social signals to sustain interest.
- Regulatory exposure: Micro‑caps often lack compliance measures and can be delisted without notice.
- Prediction uncertainty: Forecasts span several orders of magnitude, indicating no consensus.
If you’re a risk‑averse investor, DNA fails almost every checklist item. If you enjoy high‑risk “lottery‑ticket” bets, treat it like a speculative token that could disappear overnight.
How to buy DNA - a quick‑start guide (if you still want to)
- Identify an exchange that lists DNA. The token appears on a handful of low‑volume peer‑to‑peer platforms; verify the ticker symbol and contract address before depositing funds.
- Transfer a small amount of a mainstream coin (BTC, ETH, or USDT) to the exchange’s wallet.
- Place a market order for DNA, keeping the trade size under 1% of the daily volume to avoid slippage.
- Move the purchased DNA to a private wallet that supports the underlying blockchain (e.g., MetaMask for ERC‑20 tokens). Remember, the token’s contract address is not publicly documented, so you may need to import it manually.
- Monitor price using both CoinStats and CoinCodex to catch any data discrepancies.
Because the token is so illiquid, consider treating any purchase as a short‑term experiment rather than a long‑term hold.
Frequently Asked Questions
What blockchain does DNA run on?
Public sources do not specify a blockchain. Most listings assume an ERC‑20 compatible network, but without an official contract address you cannot confirm the exact chain.
Is DNA a scam?
There is no definitive evidence of fraud, but the lack of a team, roadmap, and transparent supply data makes the token extremely high‑risk. Treat it as speculative at best.
Can I mine DNA?
No mining information is available. DNA appears to be a pre‑mined token distributed through exchanges, if at all.
What are the best ways to protect my DNA holdings?
Store the token in a non‑custodial wallet that supports the token’s blockchain, enable two‑factor authentication on any exchange, and keep the private key offline.
How reliable are DNA price predictions?
Predictions vary wildly because the token lacks historical depth, trading volume, and community sentiment. Treat any forecast as speculative and not a guarantee.
Somesh Nikam
November 21, 2024 AT 07:06Wow, the DNA token really showcases how crazy micro‑caps can get 😅.
Even though the data is fuzzy, it’s a good reminder to do deep‑dive research before jumping in.
Look at the supply ambiguity – that’s a red flag you can’t ignore.
Stay cautious, keep a diversified portfolio, and don’t let hype drive your decisions.
You’ve got this!
Jan B.
November 23, 2024 AT 14:40Data is confusing but the risks are clear
emmanuel omari
November 25, 2024 AT 22:13Let’s be frank: a token that lists a circulating supply of zero is either a glaring contract bug or a deliberate obfuscation tactic, which in my view signals a lack of professionalism and opens the door to potential rug‑pull scenarios. Investors should demand verifiable contract audits before allocating any capital.
Andy Cox
November 28, 2024 AT 05:46interesting how the price hovers around 1e‑18 dollars just trading on tiny volume seems like a hobby project for some
Sidharth Praveen
November 30, 2024 AT 13:20While the numbers look scary, there’s always a chance that an unknown developer could pump the token if they finally release a real product.
That said, the liquidity crunch means even a modest buy order could swing the price dramatically.
Keep your exposure low and treat it as a speculative experiment.
If you’re comfortable with high volatility, a tiny position might satisfy the “lottery ticket” feel.
Remember, never invest more than you can afford to lose.
Sophie Sturdevant
December 2, 2024 AT 20:53The DNA token suffers from a severe paucity of on‑chain analytics and a non‑existent whitepaper, which undermines its fundamental valuation metrics.
From a risk‑adjusted capital allocation perspective, the token fails the liquidity and governance criteria, making it unsuitable for a disciplined portfolio.
Proceed only if you have a high risk tolerance and a clear exit strategy.
Nathan Blades
December 5, 2024 AT 04:26The DNA token sits at the very fringe of the crypto universe, where numbers become so infinitesimal they border on the philosophical.
Its market cap under a million dollars paints a picture of an ecosystem barely breathing.
Yet, within that thin breath lies a paradox: the potential for massive relative gains if a sudden surge of interest occurs.
The supply ambiguity, listed as zero, is a glaring red flag that any seasoned analyst will immediately flag as a sign of either a smart contract oversight or a deliberate veil of mystery.
Such opacity erodes trust, and trust is the cornerstone of any viable financial instrument.
Liquidity, measured at roughly $120k daily, is so thin that a single whale could move the price by orders of magnitude with a modest trade.
Technical indicators offer little solace; the RSI hovers around the neutral zone, while the SMA lines are practically flat due to the minuscule price changes.
The Fear & Greed Index, at a modest 50, does not capture the underlying sentiment that most users are simply unaware of this token's existence.
Forecast models swing wildly-from a 500‑fold upside to a 25% decline-highlighting the sheer uncertainty embedded in any projection.
In the absence of a community, developers, or transparent roadmaps, the token resembles a ghost ship drifting in a sea of data noise.
Yet, crypto history is littered with stories of obscure projects that unexpectedly caught the eye of a major exchange or influencer.
If such an event were to happen, the previously illiquid market could erupt into a frenzy, rewarding early adopters with outsized returns.
Conversely, without any catalyst, the token may languish forever, its price forever trapped in a scientific‑notation abyss.
For the pragmatic investor, treating DNA as a high‑risk lottery ticket, allocating a minuscule fraction of your capital, is the most sensible approach.
In short, respect the risks, stay vigilant, and never chase hype without doing the hard work of verification.
MARLIN RIVERA
December 7, 2024 AT 12:00This token is a textbook example of a rug‑pull waiting to happen.
Debby Haime
December 9, 2024 AT 19:33Hey folks, keep your eyes peeled and your risk tolerance high – if you decide to dip a toe, do it with a tiny amount and watch the charts like a hawk! 🌟
Courtney Winq-Microblading
December 12, 2024 AT 03:06The allure of chasing a phantom token like DNA is akin to reaching for shadows in a foggy night; we project hope onto numbers that may never solidify, reminding us that clarity often lies beyond the mist of speculation.
katie littlewood
December 14, 2024 AT 10:40When we examine the DNA token, we are forced to navigate a labyrinth of contradictions where the data points dance like fireflies in a dimly lit field, each flicker offering a glimpse of potential yet simultaneously casting deeper shadows of doubt.
On one hand, the token’s minuscule price and market cap suggest a sleeping giant that could, with a burst of community interest, awaken to startling heights.
On the other, the glaring absence of a whitepaper, a verifiable team, and an active community leaves us grasping at straws, questioning the very foundation upon which any valuation could be built.
The supply figures reported as zero further muddy the waters, hinting at either a technical oversight or an intentional veil designed to obfuscate true tokenomics.
Liquidity, measured in the low‑five figures daily, means that even modest trades can cause wild price swings, turning the token into a volatile playground for the brave or the reckless.
Technical metrics, such as a neutral RSI and flat SMAs, provide little guidance, offering instead a canvas upon which speculation paints its own narrative.
Forecasts range from astronomical gains to stark declines, illustrating the unpredictable nature of micro‑cap assets and the perils of anchoring on any single projection.
In this context, the most prudent strategy is to allocate only a sliver of one’s portfolio, treating DNA as a high‑risk exploratory experiment rather than a cornerstone investment.
Ultimately, whether DNA ascends to unexpected glory or fades into obscurity will be decided by factors beyond current data, underscoring the importance of humility and caution in the crypto journey.
Jenae Lawler
December 16, 2024 AT 18:13In my considered estimation, the DNA token epitomises a speculative mirage, unworthy of serious capital allocation.
Chad Fraser
December 19, 2024 AT 01:46Just a heads‑up: if you play with DNA, keep it tiny and enjoy the ride.
Jayne McCann
December 21, 2024 AT 09:20Looks like DNA is just noise.
Richard Herman
December 23, 2024 AT 16:53While you’ve highlighted the speculative angle, it’s also worth noting that even tiny positions can serve as practical learning experiences for newer investors.
Parker Dixon
December 26, 2024 AT 00:26Exactly! 🎯 Keeping the stake small not only limits exposure but also offers a sandbox to understand market dynamics without jeopardizing the portfolio. 🚀
Stefano Benny
December 28, 2024 AT 08:00Even a minuscule dab of DNA could be a catalyst for a sudden pump, defying conventional expectations.
Bobby Ferew
December 30, 2024 AT 15:33Sure, call it a rug‑pull, but for some it’s just an adrenaline‑filled gamble that adds a bit of spice to the monotony.